scholarly journals Multiple Electrophysiological Markers of Visual-Attentional Processing in a Novel Task Directed toward Clinical Use

2012 ◽  
Vol 2012 ◽  
pp. 1-11 ◽  
Author(s):  
Julie Bolduc-Teasdale ◽  
Pierre Jolicoeur ◽  
Michelle McKerral

Individuals who have sustained a mild brain injury (e.g., mild traumatic brain injury or mild cerebrovascular stroke) are at risk to show persistent cognitive symptoms (attention and memory) after the acute postinjury phase. Although studies have shown that those patients perform normally on neuropsychological tests, cognitive symptoms remain present, and there is a need for more precise diagnostic tools. The aim of this study was to develop precise and sensitive markers for the diagnosis of post brain injury deficits in visual and attentional functions which could be easily translated in a clinical setting. Using electrophysiology, we have developed a task that allows the tracking of the processes involved in the deployment of visual spatial attention from early stages of visual treatment (N1, P1, N2, and P2) to higher levels of cognitive processing (no-go N2, P3a, P3b, N2pc, SPCN). This study presents a description of this protocol and its validation in 19 normal participants. Results indicated the statistically significant presence of all ERPs aimed to be elicited by this novel task. This task could allow clinicians to track the recovery of the mechanisms involved in the deployment of visual-attentional processing, contributing to better diagnosis and treatment management for persons who suffer a brain injury.

2001 ◽  
Vol 15 (1) ◽  
pp. 22-34 ◽  
Author(s):  
D.H. de Koning ◽  
J.C. Woestenburg ◽  
M. Elton

Migraineurs with and without aura (MWAs and MWOAs) as well as controls were measured twice with an interval of 7 days. The first session of recordings and tests for migraineurs was held about 7 hours after a migraine attack. We hypothesized that electrophysiological changes in the posterior cerebral cortex related to visual spatial attention are influenced by the level of arousal in migraineurs with aura, and that this varies over the course of time. ERPs related to the active visual attention task manifested significant differences between controls and both types of migraine sufferers for the N200, suggesting a common pathophysiological mechanism for migraineurs. Furthermore, migraineurs without aura (MWOAs) showed a significant enhancement for the N200 at the second session, indicating the relevance of time of measurement within migraine studies. Finally, migraineurs with aura (MWAs) showed significantly enhanced P240 and P300 components at central and parietal cortical sites compared to MWOAs and controls, which seemed to be maintained over both sessions and could be indicative of increased noradrenergic activity in MWAs.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Matti Steimer ◽  
Sandra Kaiser ◽  
Felix Ulbrich ◽  
Johannes Kalbhenn ◽  
Hartmut Bürkle ◽  
...  

AbstractIntensive care unit (ICU)-acquired delirium is associated with adverse outcome in trauma patients with concomitant traumatic brain injury (TBI), but diagnosis remains challenging. Quantifying circadian disruption by analyzing expression of the circadian gene period circadian regulator 2 (PER2) and heme oxygenase 1 (HO1), which determines heme turnover, may prove to be potential diagnostic tools. Expression of PER2 and HO1 was quantified using qPCR from blood samples 1 day and 7 days after trauma. Association analysis was performed comparing mRNA expression levels with parameters of trauma (ISS—injury severity score), delirium, acute kidney injury (AKI) and length of ICU stay. 48 polytraumatized patients were included (equal distribution of TBI versus non-TBI) corrected for ISS, age and gender using a matched pairs approach. Expression levels of PER2 and HO1 were independent of age (PER2: P = 0.935; HO1: P = 0.988), while expression levels were significantly correlated with trauma severity (PER2: P = 0.009; HO1: P < 0.001) and longer ICU length of stay (PER2: P = 0.018; HO1: P < 0.001). High expression levels increased the odds of delirium occurrence (PER2: OR = 4.32 [1.14–13.87]; HO1: OR = 4.50 [1.23–14.42]). Patients with TBI showed a trend towards elevated PER2 (OR = 3.00 [0.84–9.33], P = 0.125), but not towards delirium occurrence (P = 0.556). TBI patients were less likely to develop AKI compared to non-TBI (P = 0.022). Expression levels of PER2 and HO1 correlate with the incidence of delirium in an age-independent manner and may potentially improve diagnostic algorithms when used as delirium biomarkers.Trial registration: German Clinical Trials Register (Trial-ID DRKS00008981; Universal Trial Number U1111-1172-6077; Jan. 18, 2018).


Nutrients ◽  
2021 ◽  
Vol 13 (2) ◽  
pp. 586 ◽  
Author(s):  
Hamilton Roschel ◽  
Bruno Gualano ◽  
Sergej M. Ostojic ◽  
Eric S. Rawson

There is a robust and compelling body of evidence supporting the ergogenic and therapeutic role of creatine supplementation in muscle. Beyond these well-described effects and mechanisms, there is literature to suggest that creatine may also be beneficial to brain health (e.g., cognitive processing, brain function, and recovery from trauma). This is a growing field of research, and the purpose of this short review is to provide an update on the effects of creatine supplementation on brain health in humans. There is a potential for creatine supplementation to improve cognitive processing, especially in conditions characterized by brain creatine deficits, which could be induced by acute stressors (e.g., exercise, sleep deprivation) or chronic, pathologic conditions (e.g., creatine synthesis enzyme deficiencies, mild traumatic brain injury, aging, Alzheimer’s disease, depression). Despite this, the optimal creatine protocol able to increase brain creatine levels is still to be determined. Similarly, supplementation studies concomitantly assessing brain creatine and cognitive function are needed. Collectively, data available are promising and future research in the area is warranted.


2011 ◽  
Vol 37 (4) ◽  
pp. 1065-1073 ◽  
Author(s):  
Emmanuel Guzman-Martinez ◽  
Marcia Grabowecky ◽  
German Palafox ◽  
Satoru Suzuki

1997 ◽  
Vol 34 (5) ◽  
pp. 553-565 ◽  
Author(s):  
ALBERTUS A. WIJERS ◽  
JAN J. LANGE ◽  
GIJSBERTUS MULDER ◽  
LAMBERTUS J. M. MULDER

Sign in / Sign up

Export Citation Format

Share Document